Approval · Notice of Compliance 11225 · 2010
MELOXICAM: Notice of Compliance 11225
Issued April 1, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11225
- Date
- April 1, 2010
- Company
- Sorres Pharma IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Non-steroidal anti-inflammatory drug (NSAID)
- Canadian reference product
- MOBICOX (Boehringer Ingelheim (Canada) Ltd.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MELOXICAM | 02328992 | — |
| MELOXICAM | 02329018 | — |